SCHEMBL17778652

SCHEMBL17778652

CNC(=O)CN=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2971432 0.77
SCHEMBL15830376 0.74
SCHEMBL24950171 0.72
SCHEMBL17274215 0.70
SCHEMBL8364339 0.70
SCHEMBL24313178 0.70 ALDH1A1 (0.40)
SCHEMBL25588780 0.70
SCHEMBL2106440 0.70
SCHEMBL3192012 0.69 MCL1 (0.43)
SCHEMBL640091 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3495354-A1 IDO1 INHIBITOR AND PREPARATION METHOD AND APPLICATION THEREOF Shandong Luye Pharmaceutical Co., Ltd. (CN) 2019-06-12 EP disclosed
US-20180200375-A1 COMPOSITIONS AND METHODS RELATING TO SALTS OF SPECIALIZED PRO-RESOLVING MEDIATORS THETIS PHARMACEUTICALS LLC (US) 2018-07-19 US disclosed
US-9724321-B2 Histone deacetylase inhibitors PRESIDENT & FELLOWS OF HARVARD COLLEGE (US) 2017-08-08 US disclosed
US-20160143874-A1 HISTONE DEACETYLASE INHIBITORS DANA-FARBER CANCER INSTITUTE, INC. 2016-05-26 US disclosed